Literature DB >> 12480265

Natural type 1 interferon producing cells in HIV infection.

Vassili Soumelis1, Iain Scott, Yong-Jun Liu, Jay Levy.   

Abstract

Natural type 1 interferon producing cells (IPCs) are in the first line of defense against infectious pathogens. Besides the known properties of type 1 interferons in inhibiting human immunodeficiency virus (HIV) replication, the recent characterization of human IPCs and the possibility to purify them for in vitro studies has greatly accelerated the study of their role in HIV infection. The blood IPC numbers and function are decreased in HIV primary infection and in advanced stages of HIV infection. Loss of circulating IPCs correlates with a high HIV viral load and the occurrence of opportunistic infections. Moreover, HIV can directly infect IPCs in vitro, providing a potential explanation for their in vivo depletion. Thus, the balance between IPCs and HIV replication might be critical in determining the control or progression of HIV infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12480265     DOI: 10.1016/s0198-8859(02)00760-7

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  15 in total

Review 1.  The plasmacytoid monocyte/interferon producing cells.

Authors:  Fabio Facchetti; William Vermi; David Mason; Marco Colonna
Journal:  Virchows Arch       Date:  2003-10-28       Impact factor: 4.064

Review 2.  Generalized immune activation and innate immune responses in simian immunodeficiency virus infection.

Authors:  Steven E Bosinger; Donald L Sodora; Guido Silvestri
Journal:  Curr Opin HIV AIDS       Date:  2011-09       Impact factor: 4.283

3.  Regulation of TNF-related apoptosis-inducing ligand on primary CD4+ T cells by HIV-1: role of type I IFN-producing plasmacytoid dendritic cells.

Authors:  Jean-Philippe Herbeuval; Andrew W Hardy; Adriano Boasso; Stephanie A Anderson; Matthew J Dolan; Michel Dy; Gene M Shearer
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-20       Impact factor: 11.205

4.  Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections.

Authors:  Ute-Christiane Meier; Rachel E Owen; Elizabeth Taylor; Andrew Worth; Nikolai Naoumov; Christian Willberg; Kwok Tang; Phillipa Newton; Pierre Pellegrino; Ian Williams; Paul Klenerman; Persephone Borrow
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells.

Authors:  Keyang Chen; Jialing Huang; Chune Zhang; Sophia Huang; Giuseppe Nunnari; Feng-xiang Wang; Xiangrong Tong; Ling Gao; Kristi Nikisher; Hui Zhang
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

6.  Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells.

Authors:  Jean-François Fonteneau; Marie Larsson; Anne-Sophie Beignon; Kelli McKenna; Ida Dasilva; Ali Amara; Yong-Jun Liu; Jeffrey D Lifson; Dan R Littman; Nina Bhardwaj
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

7.  Dendritic cells from HIV-1 infected individuals are less responsive to toll-like receptor (TLR) ligands.

Authors:  Jeffrey A Martinson; Alejandro Roman-Gonzalez; Allan R Tenorio; Carlos J Montoya; Carolyne N Gichinga; Maria T Rugeles; Mark Tomai; Arthur M Krieg; Smita Ghanekar; Linda L Baum; Alan L Landay
Journal:  Cell Immunol       Date:  2008-03-10       Impact factor: 4.868

8.  The relation of plasmacytoid dendritic cells (pDCs) and regulatory T-cells (Tregs) with HPV persistence in HIV-infected and HIV-uninfected women.

Authors:  Howard D Strickler; Jeffrey Martinson; Seema Desai; Xianhong Xie; Robert D Burk; Kathryn Anastos; L Stewart Massad; Howard Minkoff; Xiaonan Xue; Gypsyamber D'Souza; Alexandra M Levine; Christine Colie; D Heather Watts; Joel M Palefsky; Alan Landay
Journal:  Viral Immunol       Date:  2014-02       Impact factor: 2.257

9.  The interferon-induced expression of APOBEC3G in human blood-brain barrier exerts a potent intrinsic immunity to block HIV-1 entry to central nervous system.

Authors:  Elias G Argyris; Edward Acheampong; Fengxiang Wang; Jialing Huang; Keyang Chen; Muhammad Mukhtar; Hui Zhang
Journal:  Virology       Date:  2007-07-12       Impact factor: 3.616

10.  Development and management of systemic lupus erythematosus in an HIV-infected man with hepatitis C and B co-infection following interferon therapy: a case report.

Authors:  Iain J Abbott; Christina C Chang; Matthew J Skinner; Alison Street; Greg Perry; Catriona McLean; Edwina J Wright; Paul U Cameron
Journal:  J Med Case Rep       Date:  2009-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.